Journey Medical Overview
Journey Medical (DERM) has a P/E ratio of -17.11, below the sector sector average of 47.3.
Get informed when a big investor buys or sells
+ Follow-17.11
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
Journey Medical's p/e ratio stands at -17.11. That is below the sector sector average of 47.3. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.
Journey Medical sits lower the its sector benchmark (47.3) with a P/E ratio of -17.11. That is roughly 136.2% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.
Whether -17.11 is attractive depends on Journey Medical's earnings outlook, competitive position, and how peers are valued. Investors typically ask: is growth accelerating, are margins stable, and is the multiple expanding or compressing over time? The history and comparison charts below are built for those checks.
The history chart shows how Journey Medical's P/E ratio evolved across reporting periods, while the comparison chart places DERM next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.
